Ann E. Weber

Last updated
Ann E. Weber
Ann E. Weber SCI-Perkin-Medal-2017-105.jpg
Weber, Perkin Medal speech, 2017
NationalityAmerican
Alma mater University of Notre Dame, Harvard University
Awards Perkin Medal (2017), MEDI Hall of Fame (2016)
Scientific career
FieldsMedicinal chemistry, drug discovery
InstitutionsKallyope Inc., Merck Research Laboratories

Ann E. Weber is the senior vice president for drug discovery at Kallyope Inc. in New York City. She previously worked with Merck Research Laboratories (MRL), joining the company in 1987 and retiring from the position of vice president for lead optimization chemistry in 2015. She has helped develop more than 40 drug candidates including FDA-approved treatments for Type 2 diabetes. She has received a number of awards, including the Perkin Medal (2017) and has been inducted into the ACS Division of Medicinal Chemistry’s MEDI Hall of Fame.

Contents

Education

Weber grew up in Oshkosh, Wisconsin, the child of a nurse and a doctor. [1] [2] [3] There she attended Lourdes High School (Oshkosh, Wisconsin), a Catholic school. [4]

Weber earned a B.S. degree in chemistry summa cum laude from the University of Notre Dame (1982). [5] She also was able to attend Caltech for a year (1982-1983). Ann Weber took part in a summer internship for Monsanto from June 1982-August 1982 where she studied the synthesis of novel herbicides for crop protection. [6] To complete her education, Ann received a Ph.D. degree from Harvard University, where she studied synthetic organic chemistry with David A. Evans. [7] She was the first woman to receive a Ph.D. from his group, in 1987. [8]

Research

Weber joined Merck Research Laboratories (MRL) in Rahway, New Jersey, in 1987, retiring in 2015 from the position of vice president for lead optimization chemistry. In 2016 she joined Kallyope Inc. in New York City as senior vice president for drug discovery. [9] Her research areas include the development of ligands for G protein–coupled receptors, Ligand-gated ion channels and enzymes. [10]

During her career in drug discovery and development, she has published more than 80 publications. She is a co-inventor of more than 35 issued US patents. Her work has led to the development of more than 40 drug candidates including FDA-approved treatments for Type 2 diabetes. [10] Other drug candidates target obesity, [8] atherosclerosis, pain, and urinary incontinence. [11]

Beginning in 1999, Weber led the chemical team for the development of Januvia (generic: sitagliptin), a drug that inhibits the dipeptidyl peptidase-4 (DPP-4) enzyme and improves glucose tolerance to treat Type 2 diabetes. Nancy Thornberry led the corresponding biological team for the project. [12] [13] [14] The drug was approved by the FDA in October 2006. Janumet, a drug combining sitagliptin and metformin was also approved, in April 2007. In 2007, the research team at Merck received the Prix Galien USA award for their work on Januvia. [15]

Awards

Related Research Articles

<span class="mw-page-title-main">Mansukh C. Wani</span> Medicinal Chemist (February 20, 1925 - April 11, 2020 - Aged 95)

Mansukh C. Wani,, was a principal scientist (emeritus) at the Research Triangle Institute in North Carolina. He was co-discoverer of Taxol and camptothecin, two anti-cancer drugs considered standard in the treatment to fight ovarian, breast, lung and colon cancers. In 2000, Wani received an award for applied research in medicine, the Charles F. Kettering Prize, from the General Motors Cancer Research Foundation.

<span class="mw-page-title-main">P. Roy Vagelos</span> American physician and business executive

Pindaros Roy Vagelos is an American physician and business executive, who was president and chief executive officer (1985) and chairman (1986) of the American pharmaceutical company Merck & Co..

Steven Victor Ley is Professor of Organic Chemistry in the Department of Chemistry at the University of Cambridge, and is a Fellow of Trinity College, Cambridge. He was President of the Royal Society of Chemistry (2000–2002) and was made a CBE in January 2002, in the process. In 2011, he was included by The Times in the list of the "100 most important people in British science".

<span class="mw-page-title-main">Carolyn Bertozzi</span> American chemist (born 1966)

Carolyn Ruth Bertozzi is an American chemist and Nobel laureate, known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer, inflammation, and viral infections like COVID-19. At Stanford University, she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry, a nanoscience research center at Lawrence Berkeley National Laboratory.

Bruce Eliot Maryanoff FRSC is an American medicinal and organic chemist.

Paul S. Anderson is an American chemist. He worked at Merck, DuPont-Merck, and Bristol-Myers Squibb.

Prashant V. Kamat is a professor of chemistry and biochemistry and a principal scientist of the radiation laboratory, University of Notre Dame. He is affiliated with the department of chemical and biomolecular engineering as a concurrent professor. He earned his master's (1974) and doctoral degree (1979) in physical chemistry from Bombay University, and carried out his postdoctoral research at Boston University (1979–1981) and University of Texas at Austin (1981–1983).

Bruce D. Roth is an American organic and medicinal chemist who trained at Iowa State University and the University of Rochester, and, at the age of 32, discovered atorvastatin, the statin-class drug sold as Lipitor that would become the largest-selling drug in pharmaceutical history. His honours include being named a 2008 Hero of Chemistry by the American Chemical Society, and being chosen as the Perkin Medal awardee, the highest honour given in the U.S. chemical industry, by the Society of Chemical Industry, American section in 2013.

Dipeptidyl peptidase-4 inhibitors are enzyme inhibitors that inhibit the enzyme dipeptidyl peptidase-4 (DPP-4). They are used in the treatment of type 2 diabetes mellitus. Inhibition of the DPP-4 enzyme prolongs and enhances the activity of incretins that play an important role in insulin secretion and blood glucose control regulation. Type 2 diabetes mellitus is a chronic metabolic disease that results from inability of the β-cells in the pancreas to secrete sufficient amounts of insulin to meet the body's needs. Insulin resistance and increased hepatic glucose production can also play a role by increasing the body's demand for insulin. Current treatments, other than insulin supplementation, are sometimes not sufficient to achieve control and may cause undesirable side effects, such as weight gain and hypoglycemia. In recent years, new drugs have been developed, based on continuing research into the mechanism of insulin production and regulation of the metabolism of sugar in the body. The enzyme DPP-4 has been found to play a significant role.

<span class="mw-page-title-main">Cynthia A. Maryanoff</span> American chemist

Cynthia "Cyndie" Anne Maryanoff is an American organic and materials chemist. Among other awards, she received the 2015 Perkin Medal for outstanding work in applied chemistry in the U.S.A.

<span class="mw-page-title-main">Jeannette Brown</span> American organic medicinal chemist, historian, and author

Jeannette Elizabeth Brown is a retired American organic medicinal chemist, historian, and author.

<span class="mw-page-title-main">Emma Parmee</span> British chemist

Emma Parmee is a British chemist and research scientist who is a co-inventor of numerous drug patents. She was one of the leading researchers in the development of sitagliptin and was awarded a Thomas Alva Edison Patent Award in 2007 and the Society of Chemical Industry's Gordon E Moore Medal in 2009 for her contributions.

<span class="mw-page-title-main">Anil Koul</span>

Anil Koul is a scientist and former Director of the CSIR-Institute of Microbial Technology (IMTECH), a premier biomedical and biotechnology research institution under Council of Scientific and Industrial Research (CSIR) under Ministry of Science and Technology, Govt. of India.

<span class="mw-page-title-main">Nancy Thornberry</span>

Nancy A. Thornberry is the founding CEO and current chair, R&D at Kallyope Inc. in New York City. She previously worked with Merck Research Laboratories (MRL), joining the company in 1979 as a biochemist and retiring from the position of senior vice president and franchise head, diabetes and endocrinology in 2013.

Gunda I. Georg is a chemist who is currently the Professor and Head of the Department of Medicinal Chemistry, Regents Professor, McKnight Presidential Chair, Robert Vince Endowed Chair at University of Minnesota and a former Co-Editor-in-Chief of American Chemical Society's Journal of Medicinal Chemistry. Her research interests are total synthesis and semisynthesis as well as evaluating biologically active agents. A cited expert in her field, she was elected to the American Association for the Advancement of Science in 1996 and inducted in the Medicinal Chemistry Hall of Fame in 2017. In 2019, she was announced as the 2020 winner and first woman to receive the Alfred Burger Award in Medicinal Chemistry. She along with chemists, Shameem Syeda and Gustavo Blanco, are leading researchers in male contraception. Dr Georg also works with her research groups to conduct research on Alzheimer's disease, epilepsy and cancer experimental therapeutics.

Donna M. Huryn is an American medicinal and organic chemist. She received her B.A. (chemistry) from Cornell University, and Ph.D. in organic chemistry from the University of Pennsylvania. She is on the faculty at the University of Pittsburgh’s school of pharmacy, holds an adjunct appointment in the department of chemistry at the University of Pennsylvania, is the principal investigator of the University of Pittsburgh Chemical Diversity Center, and was a visiting fellow in the summer of 2017 at the University of Bologna. She is a fellow of the American Chemical Society, recipient of the ACS Philadelphia Local Section Award, has held a number of elected positions within the American Chemical Society at both the local and national levels, and is 2015 Chair of the Division of Organic Chemistry. Huryn also formed, along with a number of other scientists, the Empowering Women in Organic Chemistry Conferences in 2019. The goal was to empower and bring the research and career of all marginalized individuals in chemistry-related fields to the forefront of the scientific community. Huryn noticed how there was not enough women pursuing and maintaining a career in organic chemistry, and thus founded this organization. The Empowering Women in Organic Chemistry Conferences allowed for women leaders to present their scientific findings and hear the stories of how eminent women in the field of organic chemistry overcame the challenges they faced being female. She is associate editor of ACS Medicinal Chemistry Letters. She in also an editor of the journal Organic Reactions and co-authored the textbook Medicinal Chemistry and the article "Medicinal Chemistry: Where Are All the Women?" which appeared in the ACS Medicinal Chemistry Letters Journal. Huryn’s research focuses on the design and synthesis of small molecules probes and drugs to treat cancer, neurodegenerative and infectious diseases.

Lisa Ann Marcaurelle is an American chemist and a senior executive in multiple biotechnology companies.

<span class="mw-page-title-main">Vy Maria Dong</span> American chemist

Vy Maria Dong is a Vietnamese-American Professor of Chemistry at the University of California, Irvine (UCI). Dong works on enantioselective catalysis and natural product synthesis. She received the Royal Society of Chemistry's Merck, Sharp & Dohme Award in 2020, the American Chemical Society's Elias James Corey Award in 2019, and the UCI's Distinguished Alumni Award in 2018.

Ruth Wexler is an American industrial chemist best known as a co-discoverer of apixaban, a marketed anticoagulant; and losartan, a blood pressure treatment.

Seble-Hiwot Wagaw is an American organic chemist who is a senior leader at AbbVie pharmaceuticals outside Chicago, IL.

References

  1. 1 2 "Recognizing Outstanding Women of Science" (PDF). Weiner and Associates. May 1, 2008. Archived from the original (PDF) on May 12, 2013. Retrieved October 9, 2017.
  2. Schmidt, Christine Brennan. "WCC Merck Research Award - WCC Luncheon Address – Diversity and Me, My Life as a Woman in Chemistry". WCC Newsletter. American Chemical Society. Retrieved 9 October 2017.
  3. "Frances Weber (Obituary)". Oshkosh Northwestern. June 10, 2014. Retrieved 9 October 2017.
  4. 1 2 Lucero, Sam (February 22, 2008). "Chemist mixes up generous donation to school Lourdes High School grad gives $25,000 education grant to alma mater". The Compass. Retrieved 9 October 2017.
  5. "Alumni Profile: Ann E. Weber '82". University of Notre Dame. Archived from the original on 25 September 2020. Retrieved 9 October 2017.
  6. https://urldefense.com/v3/__https://www.linkedin.com/in/ann-weber-2b97829__;!!KwNVnqRv!CfSlrr6UN7iZRRAxctO1Hn7e65hY_aeZ9U-erHWIaFkcFuJCCCgQ8ItJTHGRdpECg_zqsayCjV-27fNpOWXADs6mw9-Ci0c$
  7. "News from SCI America: Perkin Medal to be awarded to Dr. Ann E. Weber". SCI America. 31 May 2017. Retrieved 9 October 2017.
  8. 1 2 "WOMEN IN CHEMISTRY CHOOSING TO SUCCEED Medicinal chemist Ann Weber's path has led her to a fulfilling career in industry". Chemical & Engineering News. 80 (21): 28. May 27, 2002. doi:10.1021/cen-v080n021.p028 . Retrieved 9 October 2017.
  9. "Kallyope Inc. Appoints Ann E. Weber And William J. Rieflin To Key Roles". Cision. Oct 27, 2016. Retrieved 16 October 2017.
  10. 1 2 "Ann E. Weber, PhD". ACS Division of Medicinal Chemistry. Retrieved 9 October 2017.
  11. 1 2 Gebhard, Marissa (June 9, 2010). "Ann Weber '82 wins Scarborough Memorial Award". University of Notre Dame News. Retrieved 9 October 2017.
  12. 1 2 "Women Scientists Honored For New Diabetes Oral Medication". PhRMA. April 14, 2011. Archived from the original on 17 May 2018. Retrieved 9 October 2017.
  13. Cordes, Eugene H. (2014). Hallelujah moments : tales of drug discovery. Oxford, UK: Oxford University Press. pp. 207–. ISBN   9780199337149 . Retrieved 9 October 2017.
  14. Wolfe, Josh (June 28, 2016). "Harnessing The Gut-Brain Axis". Forbes. Retrieved 9 October 2017.
  15. Stowe, Gene (April 10, 2008). "Distinguished alumna lecture is like a "mini course in medicinal chemistry"". University of Notre Dame News. Retrieved 9 October 2017.
  16. "SCI Perkin Medal". Science History Institute . 2016-05-31. Retrieved 24 March 2018.
  17. "Perkin Medal". SCI America. Retrieved 9 October 2017.
  18. Freehling, Tammi (October 18, 2016). "Chemistry alumna, Ann Weber '82, inducted into MEDI Hall of Fame". University of Notre Dame News. Retrieved 9 October 2017.
  19. "Women in STEM honored at LSC annual luncheon". LSC News. Liberty Science Center. December 11, 2013.
  20. "Sylvia M. Stoesser Lecturer 2012-13 -Ann E. Weber". University of Illinois at Urbana-Champaign. Retrieved 27 June 2019.
  21. "Industry Researchers Honored with Coveted Thomas Alva Edison Patent Award". HealthCare Institute of New Jersey. November 16, 2011. Retrieved 16 October 2017.
  22. "New Heroes of Chemistry invented medicines that help millions of people". American Chemical Society. Retrieved August 19, 2010.
  23. "Heroes of Chemistry Award". American Chemical Society. Retrieved 9 October 2017.
  24. "Discovery of the Decade" (PDF). The Prix Galien USA Awards. Retrieved 9 October 2017.